Otsuka America Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OTSUKA AMERICA, and what generic and branded alternatives to OTSUKA AMERICA drugs are available?
OTSUKA AMERICA has one approved drug.
Summary for Otsuka America
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Otsuka America
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka America | MERETEK UBT KIT (W/ PRANACTIN) | urea c-13 | FOR SOLUTION;ORAL | 020586-001 | Sep 17, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Otsuka America | BREATHTEK UBT FOR H-PYLORI | urea c-13 | FOR SOLUTION;ORAL | 020586-002 | May 10, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Otsuka America
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Otsuka America | MERETEK UBT KIT (W/ PRANACTIN) | urea c-13 | FOR SOLUTION;ORAL | 020586-001 | Sep 17, 1996 | 5,140,993 | ⤷ Sign Up |
| Otsuka America | BREATHTEK UBT FOR H-PYLORI | urea c-13 | FOR SOLUTION;ORAL | 020586-002 | May 10, 2001 | 4,830,010 | ⤷ Sign Up |
| Otsuka America | MERETEK UBT KIT (W/ PRANACTIN) | urea c-13 | FOR SOLUTION;ORAL | 020586-001 | Sep 17, 1996 | 4,830,010 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
